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Abstract
Background: Mesenchymal stem cells (MSCs) have been studied for the treatment of acute liver failure (ALF) for
several years. MSCs may exert their effect via complex paracrine mechanisms. Heme oxygenase (HO) 1, a rate-limiting
enzyme in heme metabolism, exerts a wide range of anti-inflammatory, anti-apoptotic and immunoregulatory effects
in a variety of diseases. However, the relationship between MSCs and HO-1 in the treatment of ALF is still unclear. We
investigated the preventive and therapeutic potential of intravenously administered BMSCs.
Methods: Bone marrow-derived mesenchymal stem cells (BMSCs) obtained from Sprague–Dawley rats were isolated
and cultured. We employed BMSCs, hemin (a HO-1 inducer) and zinc protoporphyrin (ZnPP, the HO-1 activity inhibitor)
in D-galactosamine (D-Gal)/lipopolysaccharides (LPS)-induced ALF rats. Rats were sacrificed at days 1, 3, 5, and 7 post-
transfusion, respectively. Blood samples and liver tissues were collected. Hepatic injury, HO-1 activity, chemokines,
inflammatory cytokines, the number and oxidative activity of neutrophils, ki67, and TUNEL-positive cells were evaluated.
Results: HO-1 induction or BMSCs transplantation attenuated D-galactosamine/lipopolysaccharide-induced increases in
alanine aminotransferase, aspartate aminotransferase, total bilirubin (TBIL), ammonia, and inflammatory cytokines.
Treatment with hemin or BMSCs also inhibited neutrophil infiltration, oxidative activity, and hepatocyte apoptosis. The
protective effect of BMSCs was partially neutralized by ZnPP, suggesting the key role of HO-1 in the process.
Conclusions: These findings may correlate with inhibition of nuclear factor-κ B activation. BMSCs ameliorated ALF
by increasing the HO-1 expression, which reduced PMN infiltration and function, and played an important anti-
inflammatory and anti-apoptotic role.
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Background
Acute liver failure (ALF) is a clinical manifestation of
sudden and severe hepatic injury associated with a high
mortality rate. Orthotopic liver transplantation (OLT) is
the only effective treatment [1, 2]. However, the shortage
of available donor livers and multiple postoperative com-
plications limit widespread clinical application of OLT
[3]. No artificial liver device has emerged as a way to
bridge patients with acute liver disease to transplantation
or recovery. Recently, some stem cell therapies have
shown promise in treating acute liver failure and drug-
induced liver injury [4–6].
Polymorphonuclear neutrophils (PMNs) are part of the
innate immune system and migrate to sites of inflamma-
tion. In immune and inflammatory disorders, PMNs are
released from the marrow and circulate to liver. Inflamma-
tory mediators, such as tumor necrosis factor (TNF)-α,
interleukin (IL)-1β and IL-8 released from dying or dead
hepatocytes, are potent promoters of PMN infiltration into
the liver parenchyma [7, 8]. These effects trigger PMN acti-
vation, including prolonged adherence-dependent oxidative
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stress and degranulation [9]. Neutrophils express Fas
ligand, and they play a key role in killing microorgan-
isms or damaged cells, thereby limiting disease
spread. These same functions mean that neutrophils
can cause hepatocytes apoptosis [10]. PMNs are es-
sential for a healthy liver although excessive activation
of neutrophils perpetuates liver injury.
Mesenchymal stem cells (MSCs) are stroma-derived
cells occurring in several tissues, such as bone marrow,
adipose tissue, skeletal muscle, synovium, umbilical cord,
and cord blood [11]. The ability of MSCs to modulate
cell function in innate and adaptive immune systems
suggests a therapeutic role in inflammatory diseases [12].
In addition to promoting differentiation in regeneration
therapy, MSCs show low immunogenicity. They play an
immunoregulatory role in the secretion of mediators, in-
cluding transforming growth factor (TGF)-β, indoleamine
2,3-dioxygenase, inducible nitric oxide synthase (iNOS),
prostaglandin E2 (PGE2), IL-10, and TNF-α-stimulating
gene (TSG)-6 [13]. These properties suggest great thera-
peutic potential for the treatment of immune and inflam-
matory disorders. However, the underlying mechanisms of
MSCs in ALF remain elusive.
Heme oxygenase (HO) comprises a group of ubiquitous
enzymes [14]. HO is expressed in three isoforms: HO-1, 2,
and 3. HO-1 is a rate-limiting enzyme in heme metabolism,
catalyzes heme into CO, free iron, and biliverdin, and exerts
a wide range of anti-inflammatory, anti-apoptotic, and im-
munoregulatory effects in a variety of diseases [14–16]. It is
upregulated by pharmacological agents in D-galactosamine
(D-Gal)/lipopolysaccharide (LPS)-induced liver injury [17].
A recent study suggested that MSCs transplantation upre-
gulates the expression of HO-1 [13].
Several studies have demonstrated the therapeutic ef-
fect of MSCs in ALF [4–6]. However, the relationship
between HO-1, neutrophils, and the therapeutic effect of
MSCs in ALF has not been demonstrated. Therefore,
this study sought to determine whether MSCs protected




Male Sprague–Dawley rats aged 3–4 weeks and weighing
90–100 g each were used as BMSC donors. Male rats aged
6–7 weeks and (weighing 190–200 g each were used as
BMSC recipients. All the rats were purchased from the
Laboratory Animal Center of the Affiliated Drum Tower
Hospital of Nanjing University Medical School, China,
housed in a ventilated cabinet under controlled air pres-
sure and temperature conditions, and exposed to alternat-
ing 12 h light/dark cycles. The rats were provided with
sterile water and standard pellets of rodent diet. The
animals were sacrificed.
Preparation of bone marrow-derived mesenchymal stem
cells (BMSCs)
BMSCs obtained from Sprague–Dawley rats were iso-
lated and cultured according to an established protocol
[5]. The rats were sacrificed by cervical dislocation, the
femurs and tibias were excised and the soft connective tis-
sue was removed. The bone marrow cells were harvested
by flushing the marrow cavity with complete culture
medium. Cells were collected by gradient centrifugation
over a Ficoll Histopaque layer (20 min, 400 × g, density
1.077 g/ml) and seeded at a density of 1 × 106 cells/cm2 in
growth medium containing low-glucose Dulbecco's modi-
fied Eagle's medium (DMEM; Gibco, Grand Island, NY,
USA) supplemented with 10% fetal bovine serum, penicil-
lin (100 U/ml), and streptomycin (100 mg/ml). The nonad-
herent cells were removed after the first 24 h and changed
every 3–4 days thereafter. When the cells reached 80%
confluence, they were detached using 0.25% (w/v) trypsin-
ethylenediaminetetraacetic acid and replated at a density of
1 × 104cells/cm2 for expansion. We used flow cytometry
(FACS Aria II; BD Biosciences, San Jose, CA, USA) to
identify the MSCs. We used antibodies targeting rat anti-
gens cluster of differentiation (CD)29, CD34, CD44, CD45,
and CD90 (BD Biosciences). Positive cells were counted
and compared with the signal corresponding to the im-
munoglobulin isotype. The BMSCs obtained between the
third and seventh passages were used.
Experimental design and animal groups
ALF was induced by intraperitoneal injection of 0.8 g/kg
D-galactosamine (D-Gal) and 20 μg/kg LPS. The rats were
randomly divided into five groups: (1) control; (2) ALF; (3)
ALF + MSC; (4) ALF + MSC+ zinc protoporphyrin
(ZnPP); and (5) ALF + hemin. The control rats were
injected with an equal volume of normal saline in parallel.
One hour after ALF induction, either phosphate-buffered
saline (PBS) or 106 MSCs in a volume of 1.0 mL were
transfused into the caudal tail vein over a period of 3 min.
Hemin (40 μmol/ kg body weight; Sigma–Aldrich, St.
Louis, MO, USA) or ZnPP (50 μmol/kg body weight;
Sigma–Aldrich) were administered intraperitoneally 1 h
after induction of liver injury. The doses of D-Gal, LPS,
hemin, and ZnPP were based on our preliminary studies.
Rats were evaluated every 6 h and euthanized if they ap-
peared moribund.
Survival study
Ten rats in each group were used for the survival study.
Rats that lived for more than 12 days after transplant-
ation were considered as survivors.
Collection of serum samples and hepatic tissue specimens
Rats were euthanized on days 1, 2, 3, 5, and 7 post-
transfusion. To detect serum cytokines on days 0, 1, 2, 4,
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and 6 after infusion of BMSCs, blood samples were col-
lected from the tail vein 24 h before euthanasia. Liver
tissues were excised and processed for further RNA ana-
lysis and Western blot. The remaining tissue was fixed
and processed for histology and immunohistochemistry.
Measurement of hepatic enzyme and cytokine levels after
cell transfusion
The plasma levels of alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) after treatment were
measured with an automated biochemical analyzer (iMa-
gic-M7; Mindray, Shenzhen, China). The levels of plasma
IL-1β, IL-6, and TNF-α were detected using a commercially
available ELISA kit (eBioscience, San Diego, CA, USA).
Measurement of mRNA expression in hepatic tissues by
quantitative reverse transcriptase polymerase chain
reaction (RT-PCR)
Total RNA was isolated from frozen liver using TRIzol
reagent (Invitrogen, Carlsbad, CA, USA). First-strand
cDNA was synthesized using the Superscript II Reverse
Transcriptase Kit (Invitrogen). Quantitative (q) PCR was
performed using Power SYBR Green PCR Master Mix
(Takara, Tokyo, Japan). The relative level of gene expres-
sion was normalized to that of an internal control (β-actin)
and calculated using the 2−ΔΔCT method. The primer se-
quences were as follows:
HO-1 sense primer sequence: 5'-ACCCCACCAAGTT
CAAACAG-3'; HO-1 antisense prime sequence: 5'-
GAGCAGGAAGGCGGTCTTAG-3'; IL-1β sense primer
sequence: 5'-TCAATCAGCCCTTTACTGAAGATG-3';
IL-1β antisense prime sequence: 5'-TGCTTGACGAT
CCTTATCAATTTG-3'; IL-6 sense primer sequence: 5'-
CAAAGCCAGAGTCATTCAAGC-3'; IL-6 antisense
prime sequence: 5'-GGTCCTTAGCCACTCCTTCTGT-
3'; TNF-α sense primer sequence: 5'-CCCAATCTGT
GTCCTTCTAACT-3'; TNF-α antisense prime sequence:
5- CACTACTTCAGCGTCTCGTGT-3'; CXCL-1 sense
primer sequence: 5-TCTTTCTGGCTTAGAACAAAGG
GGC-3; CXCL-1 antisense prime sequence: 5-AGTAA
AGGTAGCCCTTGTTTCCCCC-3; CXCL-2 sense pri-
mer sequence: 5-TCATAGCCACTCTCAAGGG -3; CX
CL-2 antisense prime sequence: 5-TTGGTTCTTCCGT
TGAGGG-5; CXCL12 sense primer sequence: 5′-GAT
TGT AGC CCG GCT GAA GA -3′; CXCL12 antisense
prime sequence: 5′-TTC GGG TCA ATG CAC ACT
TGT -3; β-actin sense primer sequence: 5'-GCG
CTCGTCGTCGACAACGG-3'; β-actin antisense primer
sequence: 5'-GTGTGGTGCCAAATCTTCTCC-3'.
Experiments were performed in replicate using three
different samples of each group, and technical triplicates
were obtained for the analysis of each gene expression.
The mean relative expression of each gene in the groups
was used for statistical analysis.
Histological and immunohistochemical study
At the end of the study, livers were removed and
weighed. The liver samples were fixed in 4% paraformal-
dehyde for 24 h before processing for histological and
immunohistochemical analyses. Fixed liver samples were
dehydrated and paraffin-embedded. Three fragments,
each measuring less than 3 mm in thickness, were ob-
tained from each liver. Sections were stained with
hematoxylin and eosin for pathological assessment.
Apoptosis was assessed by TdT-mediated dUTP nick
end-labeling (TUNEL) staining, using a Cell Death
Detection Kit (Roche, Mannheim, Germany). Cells testing
positive for proliferating cell nuclear antigen (Ki67) were
detected using specific antibodies (Aviva Systems Biology,
Beijing, China). Formalin-fixed paraffin-embedded liver
sections were deparaffinized and stained for HO-1 and
myeloperoxidase (MPO). Images were captured, and the
labeled cell area manually quantified by two independent
operators using Image-Pro Plus software (Media Cyber-
netics, Bethesda, MD, USA), five different fields were
taken in each individual sample. Then the average number
of the positive cells was calculated.
Histological analysis
The histological changes were evaluated according to
the method reported by Camargo et al. [18]. The stained
sections were graded as follows: grade 0, minimal or no
evidence of injury; grade 1, mild injury with cytoplasmic
vacuolation and focal nuclear pyknosis; grade 2, moder-
ate to severe injury with extensive nuclear pyknosis,
cytoplasmic hypereosinophilia, and loss of intercellular
borders; grade 3, severe necrosis with disintegration of
hepatic cords, hemorrhage, and neutrophil infiltration.
Western blotting analysis of Bcl-2, Bax, Nrf2, and HO-1
expression in liver tissue
The total, cytosolic, and nuclear protein content of fro-
zen hepatic samples was extracted according to the
method described in the protein extraction kit (Active
Motif, Carlsbad, CA, USA). Protein concentrations were
determined using BCA protein assay kit (Sigma–Aldrich).
Protein extracts were fractionated on 12% SDS-PAGE and
transferred to a nitrocellulose membrane. The membrane
was blocked with 5% (w/v) fat-free milk in Tris-buffered
saline (TBS) containing 0.05% Tween 20, followed by in-
cubation with a rabbit anti-HO-1 polyclonal antibody
(1:2000), rabbit anti-Bcl-2 polyclonal antibody (1:1000) or
rabbit anti-Bax polyclonal antibody (1:1000) at 4 °C over-
night. The membrane was treated with horseradish
peroxidase-conjugated goat anti-rabbit secondary anti-
body (1:10,000). Antibody binding was visualized with an
ECL chemiluminescence system and short exposure of the
membrane to X-ray films (Kodak, Tokyo, Japan). Signal
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intensities were quantified by densitometry using Image J
software (NIH, Bethesda, MD, USA).
Measurement of nuclear factor (NF)-κB (p65) binding
ability
The nuclear protein fraction in each experimental animal
was used for the NF-κB-DNA binding assay. The NF-κB-
DNA binding activity was assessed using an NF-κB (p65)
transcriptional factor ELISA kit (Cayman Chemical
Company, Ann Arbor, MI, USA).
Measurement of HO-1 activity
HO-1 activity was determined via bilirubin formation as
described by Hu et al. [19]. The reaction mixture consisted
of 200 μL 4 mmol/L liver supernatant, 50 μL 1 mmol/L
liver cytosol, 20 μL 1 mmol/L heme B solution, 200 μL
2.75 mmol/L β-NADPH solution, and 530 μL 2 mmol/L
MgCl2 in 100 mmol/L phosphate buffer (pH 7.4). The
samples were incubated in a 37 °C water bath in the dark
for 1 h. The reaction was stopped by placing the samples
in ice. An NADPH-free reaction mixture was used as a
control. The absorbance of the samples was measured
using a UV/visible spectrophotometer (Ultrospec 2000;
Thermo Fisher Scientific, Waltham, MA, USA) at 464 nm
and 530 nm. Bilirubin levels were calculated from the dif-
ference in absorbance at 464 nm and 530 nm. The values
were expressed as pmol bilirubin/mg protein formed/h.
Malondialdehyde (MDA) and MPO activity
Lipid peroxidation in the livers was determined by meas-
uring the thiobarbituric acid-reactive substances in the
liver tissue homogenate using an MDA assay kit (Beyotime
Institute of Biotechnology, Beijing, China). Liver MPO ac-
tivity was determined using an MPO activity assay kit
(Jiancheng Biochemistry Co., Nanjing, China). Three liver
samples in each pup at different time points were used for
each analysis.
Oxidative activity
Oxidative activity was determined by staining with dihy-
drorhodamine 123 (DHR123; Sigma–Aldrich), a nonflu-
orescent agent converted by cellular oxidation to the
fluorescent dye rhodamine 123 (R123). Heparinized
whole blood samples (100 μL) from each group were in-
cubated with DHR123 (1.0 μM) in 400 μL RPMI 1640 at
37 °C under sterile conditions. Leukocytes were isolated
by ammonium chloride lysis of red blood cells. Cells in
these gates were analyzed for fluorescence intensity.
Cell-associated R123 fluorescence within the three popu-
lations was determined using a flow cytometer (FACS
Aria II; BD Biosciences). Background fluorescence in
samples incubated without R123 was subtracted from
the total fluorescence to determine the oxidative activity
in each individual sample.
Statistical analysis
All the data were expressed as means ± standard deviation
(SD) and compared via analysis of variance followed by a
Student’s t test. In the mortality study, time-to-survival
data were analyzed using the Kaplan–Meier method and
compared via the log-rank test. Differences between values
were considered significant at p < 0.05.
Results
BMSC isolation and characterization
BMSCs were isolated from Sprague–Dawley rats. The ad-
herent cells showed a colony-like distribution after inocula-
tion into the culture flask, as seen under a phase-contrast
microscope. These cells exhibited a spindle-shaped, fibro-
blastic morphology (Additional file 1: Figure S1A). The
BMSCs were identified by flow cytometry. Cells were incu-
bated with fluorescein isothiocyanate (FITC)-conjugated
antibodies. The BMSCs isolated from rat were positive for
CD29 (98.9%), CD44 (97.1%), and CD90 (99.2%), and
negative for CD34 (0.8%) and CD45 (2.0%), which sug-
gested high purity after the third passage (Additional file 1:
Figure S1B).
BMSCs attenuate ALF-related injury via induction of HO-1
In the ALF group, 80% of rats died within 5 days. By
contrast, 80% of rats receiving BMSCs survived for
12 days after ALF induction (Fig. 1a). All the changes
were quantitatively evaluated using injury scores (Fig. 1b).
The surviving animals also had a dramatic decrease in
ALT, AST, total bilirubin (TBIL), and ammonia (NH3)
levels (Fig. 1c). Histology showed a normal lobular archi-
tecture and cell structure of the liver in control animals,
but extensive portal inflammation, hemorrhagic necrosis,
increased inflammatory cell infiltration in the liver of the
ALF group, and the hepatocytes had swollen cytoplasm.
BMSCs treatment restored normal histology (Fig. 1d).
ALT, AST, TBIL, and NH3 were increased dramatically
in the ALF group compared with the control group. To
establish whether suppression of endogenous HO-1 ac-
tivity affected the protective effect of BMSCs, we treated
rats with ZnPP to suppress hepatic HO activity. We
found that inhibition of HO-1 by ZnPP partly abolished
the hepatoprotective effect of BMSCs, as confirmed by
biochemical or histological parameters (Fig. 1c). The
HO-1 induction by hemin in D-Gal/LPS-treated rats
was investigated. D-Gal/LPS-induced hepatotoxicity was
markedly attenuated in rats with hemin (Fig. 1).
Compared with the control and ALF groups, BMSCs
and hemin induced a significant increase in HO-1
mRNA and protein expression in the liver (Fig. 2a–c).
Immunohistochemical analysis showed the distribution
of HO-1 protein after BMSC treatment. The positive
staining of HO-1 protein was mainly observed in hepatic
parenchymal cells (Fig. 2c). The control rats showed
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little positive staining in the liver, while the mRNA
and protein levels of HO-1 were not affected by
ZnPP. The HO-1 activity suggested an increased en-
zymatic function after BMSC and hemin treatment,
and the increased HO-1 activity was reduced to base-
line level by ZnPP (Fig. 2d). Nuclear factor-erythroid
2 p45-related factor 2 (Nrf2) is associated with cyto-
protective genes, such as HO-1 [20, 21]. As shown in
Fig. 2e, MSCs transplantation significantly increased
the expression of Nrf2.
BMSCs inhibit neutrophil infiltration and oxidative activity
via induction of HO-1
Neutrophils play an important role in ALF, and pro-
inflammatory cytokines promote their activation and in-
filtration in the liver, during chemokine and adhesion
Fig. 1 Transplanted BMSCs, via HO-1, significantly improve liver function, inflammation, and survival in ALF induced by D-Gal/LPS. a Kaplan-Meyer
curve showing survival over 12 days (n = 10 per group) following various treatments. BMSCs significantly decreased mortality of ALF (p < 0.05),
whereas Znpp treatment blocked this protective effect (p < 0.05). Hemin also resulted in a significant decrease in mortality (p < 0.05). b Liver injury
scores (n = 6 per group) were significantly decreased by BMSCs (p < 0.05); Znpp reversed this protective effect (p < 0.05). Hemin treatment resulted in a
decrease in injury score (p < 0.05). c Serum ALT, AST, NH3, and TBIL (n = 10 per group). BMSCs infusion significantly decreased liver enzymes over 7 days
after infusion (p < 0.05); Znpp reversed this effect (p < 0.05). Hemin treatment resulted in a significant decrease in liver function tests (p < 0.05). d
Representative images of hematoxylin and eosin staining (×100/×200). Treatment groups: control, ALF, ALF followed by intravenous MSCs (ALF +MSC)
1 h post-induction, ALF followed by MSCs and Znpp (ALF +MSC + Znpp) 1 h post-induction, and ALF followed by hemin (ALF + hemin) 1 h post-
induction. Data are mean ± SD. (*p < 0.05 vs. control group; $p < 0.05 vs. ALF group; #p < 0.05 vs. ALF +MSC group). Abbreviations: ALF acute liver failure,
ALT alanine aminotransferase, AST aspartate transaminase, BMSCs bone marrow-derived mesenchymal stem cells, D-Gal d-Galactosamine, HO-1 heme
oxygenase-1, LPS lipopolysaccharide, NH3 ammonia, TBIL total bilirubin, Znpp zinc protoporphyrin
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Fig. 2 BMSCs increase HO-1 expression and activity, and Nrf2 expression in liver. a Quantitative reverse transcription PCR showing BMSC infusion
or hemin increases expression of HO-1 relative to the ALF group (n = 6 per group, p < 0.05). Znpp did not decrease HO-1 mRNA levels. b Western
blot shows that BMSCs infusion or hemin treatment significantly increases HO-1 protein (p < 0.05), but Znpp does not decrease HO-1 protein
levels. Densitometry used to calculate normalized protein ratio (vs. β-actin standard). c Immunohistochemical stain (brown) of HO-1 in livers 72 h
after D-Gal/LPS treatment (magnification × 200). BMSCs infusion or hemin treatment significantly increased HO-1 staining; Znpp did not decrease
HO-1 staining. d HO-1 enzyme activity in livers 72 h after D-Gal/LPS treatment (n = 6 per group). HO-1 activity was significantly increased by
BMSCs (p < 0.05); Znpp decreased HO-1 activity (p < 0.05). Hemin treatment also increased liver HO-1 activity (p < 0.05). e Western blot results
showing that BMSCs increase Nrf2 expression of Nrf2 relative to the ALF group (p < 0.05); Znpp decreased Nrf2 expression (p < 0.05). Hemin treatment
also increased Nrf2 protein levels (p < 0.05). Densitometry used to normalize protein levels (β-actin standard). Treatment groups: control, ALF, ALF
followed by intravenous MSCs (ALF +MSC) 1 h post-induction, ALF followed by MSCs and Znpp (ALF +MSC + Znpp) 1 h post-induction, and ALF
followed by hemin (ALF + hemin) 1 h post-induction. Data are mean ± SD. (*p < 0.05 vs. control group; $p < 0.05 vs. ALF group; # p < 0.05 vs. ALF +MSC
group). Abbreviations: ALF acute liver failure, BMSCs bone marrow-derived mesenchymal stem cells, D-Gal d-Galactosamine, HO-1 heme oxygenase-1,
LPS lipopolysaccharide, Nrf2 nuclear factor-erythroid 2 p45-related factor 2, Znpp zinc protoporphyrin
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molecule expression [22, 23]. Therefore, we examined
the effect of BMSCs on neutrophil infiltration. Cells
positive for MPO (a neutrophil marker) were observed
in liver. The number of MPO-positive cells, MPO activ-
ity and MDA level were markedly increased in the ALF
group and were downregulated by BMSC treatment. The
inhibitory effect of BMSCs in neutrophils was attenuated
by addition of ZnPP, and hemin also inhibited neutrophil
infiltration and activity (Fig. 3).
To assess the oxidative burst, neutrophils were gated,
using flow cytometry, by their characteristic forward and
side scatter profiles and analyzed for fluorescence intensity
(Additional files 2 and 3: Figure S4 and Figure S5). Blood
sample gating is illustrated in Fig. 3. Fluorescence-
activated cell sorting results were presented as histograms
representing the number of cells. The intensity of R123
fluorescence generated by incubating blood samples with
DHR123 is shown in Fig. 3e. At 1, 2, and 3 days after in-
jury, D-Gal/LPS-treated rats showed increased intensity of
R123 fluorescence in neutrophils due to oxidative burst,
which was notably alleviated by BMSCs or hemin treat-
ment. The inhibitory effect of BMSCs on R123 fluores-
cence intensity of neutrophils was attenuated after
addition of ZnPP. We also determined the impact of
MSCs on the expression of chemokines CXCL1, CXCL2,
and CXCL12 in the liver using RT-PCR. D-Gal/LPS in-
creased the expression of CXCL1 and CXCL2 genes sig-
nificantly, which induced PMN infiltration into the liver,
while the CXCL12 expression declined slightly. Trans-
plantation of MSCs led to a significant decrease in CXCL1
and CXCL2 expression, similar to the events following
HO-1 induction. However, HO-1 inhibition increased
CXCL1, but not CXCL2 expression (Fig. 3f).
BMSCs reduced ALF-related apoptosis and promoted
regeneration via induction of HO-1
Recent studies demonstrated that BMSCs decreased
apoptosis in damaged liver. To determine the role of
HO-1 in this process, we investigated the effect of
BMSCs on ALF-related apoptosis. We found a signifi-
cant increase in the number of TUNEL-positive cells
(Fig. 4a) in the ALF group compared with the control
group, which was reduced markedly 2 days after BMSCs
or hemin treatment. The balance between the expression
of anti-apoptotic protein Bcl-2 and pro-apoptotic pro-
tein Bax not only regulates apoptosis but also served as
an important indicator of apoptosis [25]. Western blot
(Fig. 4c) showed that the Bcl-2/Bax ratio was reduced in
ALF compared with the control rats, and was upregu-
lated 2 days after BMSC or hemin treatment. The Bcl-2/
Bax ratio was downregulated by ZnPP treatment.
To determine the effect of BMSCs on liver regeneration,
the number of Ki-67-positive hepatocytes were counted
and compared. Ki-67-positive cells were considered to be
proliferative. BMSCs significantly upregulated the number
of Ki-67-positive hepatocytes compared with the control
and ALF groups (Fig. 4a), which was decreased by the
addition of ZnPP. Hemin also promoted the number
of Ki-67-positive hepatocytes, but the number of Ki-
67-positive hepatocytes was lower than that of BMSCs
(Fig. 4b).
BMSCs decreased inflammatory response via induction of
HO-1
Pro-inflammatory cytokines play an important role in
liver injury [24]. Phosphorylation of the NF-κB p65 sub-
unit is associated with an increase in NF-κB activity, and
plays an important inflammatory role [25]. As shown in
Fig. 5a, D-Gal/LPS injection significantly induced phos-
phorylation of NF-κB p65 subunit. BMSCs markedly re-
duced the phosphorylation of NF-κB p65 subunit.
Following the inhibition of HO-1 activity in liver, the
phosphorylation of NF-κB p65 subunit increased again.
Hemin decreased the phosphorylation of NF-κB p65
subunit. To investigate whether BMSCs affected NF-κB
DNA-binding activity, an NF-κB activity assay was per-
formed. The D-Gal/LPS-induced increase in DNA bind-
ing of NF-κB, BMSCs and hemin downregulated the
DNA binding of NF-κB, and ZnPP increased the NF-κB
DNA binding activity (Fig. 5b).
Mitogen-activated protein kinases (MAPKs) play an
important role in the control of cellular responses to in-
flammatory stimuli. After induction of ALF, D-Gal/LPS
resulted in the upregulation of phosphorylation of p38,
extracellular-regulated protein kinases (Erk) and C-Jun
N-terminal kinase (JNK), and BMSC transplantation at-
tenuated JNK expression. Increased phosphorylation of
p38 was minimally affected by BMSCs, and inhibition of
HO-1 activity did not affect the phosphorylation of JNK,
while hemin increased the phosphorylation of p38 and
JNK. The levels of IL-6 in liver (Fig. 5c), as well as IL-1B
and TNF-α were elevated in the ALF group compared with
the control group. The expression of pro-inflammatory cy-
tokines was decreased after BMSCs or hemin treatment,
and inhibition of HO-1 activity with ZnPP increased the
levels of IL-6, IL-1β, and TNF-α compared with BMSC
treatment. Increased mRNA levels of IL-1β, IL-6, and
TNF-α (Fig. 5c) were also detected, especially in the ALF
group. BMSCs or hemin treatment downregulated the
mRNA level of IL-1β, IL-6, and TNF-α. However, the anti-
inflammatory effect of BMSC was partly abrogated by
ZnPP treatment.
Discussion
MSCs have been studied for the treatment of liver failure
for several years. The possible mechanisms are mediated
via complex paracrine pathways, underscoring their
significance as an important cellular source in liver
Zhang et al. Stem Cell Research & Therapy  (2017) 8:70 Page 7 of 13
Fig. 3 (See legend on next page.)
Zhang et al. Stem Cell Research & Therapy  (2017) 8:70 Page 8 of 13
regenerative medicine. Previous studies suggested that
rodent or human MSCs differentiate into hepatocytes in
vitro. However, the role of MSCs transplantation in regen-
eration of hepatocytes remains controversial [26]. The ma-
jority of recent studies indicated that the trophic and
immunomodulatory factors secreted by MSCs play a crucial
role in liver injury [4, 5, 12, 27]. In the current study, we
demonstrated that MSCs increased the mRNA and protein
levels of HO-1 in liver, which led to significant improve-
ment in liver injury, inflammatory response, and neutrophil
infiltration. In vivo imaging and fluorescence microscopy
demonstrated that Dir-labeled MSCs were detected in the
liver (Additional files 4 and 5: Figure S2 and Figure S3).
These findings show that MSCs home to sites of liver in-
jury. Taken altogether, our study suggests that MSCs treat-
ment alleviates ALF through the induction of HO-1.
HO-1 is a stress-response protein, which is upregu-
lated by a broad spectrum of inducers, including heme,
heavy metals, nephrotoxins, cytokines, endotoxins, and
oxidative stress [13, 28, 29]. Nrf2 is a transcription factor
mediating the Nrf2-antioxidant response element signal-
ing pathway, which protects against oxidative stress.
Therefore, Nrf2 plays an important therapeutic role in
inflammatory diseases [20, 21, 30]. Our results suggested
that MSC transplantation might exert a protective effect
by activating the Nrf2 pathway. The present study
showed that the hepatic expression of Nrf2 and its target
gene, HO-1, were significantly increased following treat-
ment with BMSCs. HO-1 activity was also markedly in-
duced by BMSCs. The data confirm the HO-1-inducing
property of BMSCs [13, 31]. However, the mechanism
involved in the activation of HO-1 protein expression by
BMSCs in rats remains to be investigated.
Recent studies have demonstrated that HO-1 regulated
neutrophil infiltration and activation. Konrad et al. [32]
showed that the anti-inflammatory role of HO-1 is me-
diated via inhibition of neutrophil infiltration from bone
marrow. Konrad et al. [33] attributed the anti-
inflammatory effects of HO-1 primarily to inhibition of
PMN release from bone marrow. Neutrophils are an im-
portant group of innate immune cells in the first line of
defense against disease. Neutrophils are generated in
bone marrow and released into the circulation. They are
rapidly recruited to the sites of injury and inflammation
[34]. During liver injury in ALF, neutrophils are activated
by pro-inflammatory cytokines and increase tissue damage
by enhanced oxidative burst and reactive oxygen species
[35]. Excessive neutrophil infiltration and activation can
have adverse effects. Consistent with previous studies [35],
our findings suggest that injection of D-Gal/LPS increase
the migration of neutrophils, elevate their oxidative burst
levels, enhance hepatic MPO activity, and upregulate
MDA expression. These effects were downregulated by
BMSCs. The protective effect of BMSCs was attenuated
after addition of ZnPP. The excessive activation and infil-
tration of neutrophils leads to secondary inflammation in
the liver or bystander tissues [36, 37]. Our findings are
consistent with other studies reporting that MSCs dampen
oxidative and inflammatory activity of neutrophils of pre-
mature neonates in vitro [38]. The chemokines CXCL1
(keratinocyte-derived chemokine) and CXCL2 (macro-
phage inflammatory protein-2) are crucial for neutrophil
migration to inflammatory sites [32]. CXCL1 and CXCL2
are 90% identical in their amino acid sequences and act
via the chemokine receptor CXCR2, which is a G protein
chemokine receptor expressed on neutrophils [39]. Hep-
atic CXCL1 mRNA levels correlated positively with liver
PMN infiltration in the alcoholic hepatitis period [40].
Our results showed that MSCs transplantation signifi-
cantly suppressed CXCL1 and CXCL2 genes, while
(See figure on previous page.)
Fig. 3 BMSCs inhibit neutrophil infiltration into liver, MPO activity, MDA expression, and neutrophil oxidative burst via HO-1 induction in D-Gal/
LPS-induced ALF. a Myeloperoxidase (MPO, a neutrophil marker) staining (brown) in livers 72 h after D-Gal/LPS (magnification × 400). b Number of
MPO-positive cells in each group (n = 6 per group). ALF rats had the most MPO-positive cells, BMSCs infusion significantly decreased the number
of MPO-positive cells (p < 0.05). Znpp resulted in more MPO- + cells than BMSC alone (p < 0.05). c MPO activity was significantly increased by
D-Gal/LPS vs. control rats (p < 0.05). BMSCs decreased MPO activity induced by ALF (p < 0.05); Znpp blunted the BMSC effect. Hemin treatment
after BMSC was also associated with reduced MPO activity (p < 0.05) (n = 6 per group). Livers collected 24 and 72 h following D-Gal/LPS. d
Malondialdehyde (MDA) levels (n = 6 per group) were increased significantly in ALF livers. BMSCs significantly reduced MDA expression after ALF
(p < 0.05). Znpp administration blunted the effect of BMSC (p < 0.05). Hemin treatment after BMSC was also associated with decreased MDA levels
(p < 0.05). e R123 fluorescence of neutrophils (oxidative stress) at 24 h and 72 h after D-Gal/LPS (n = 6 per group). Fluorescence intensity increased
significantly in ALF livers. BMSCs infusion resulted in a significant reduction of fluorescence intensity (p < 0.05), whereas Znpp administration
blunted the BMSC effect on fluorescence (p < 0.05). Hemin after BMSC was also associated with decreased fluorescence vs. ALF (p < 0.05), f
Quantitative reverse transcription PCR for mRNA levels of CXCL1, CXCL2, and CXCL12 in livers. CXCL1 and CXCL2 expression increased significantly
in ALF livers (p < 0.05). BMSCs infusion decreased the mRNA levels of CXCL1 and CXCL2 vs. ALF levels (p < 0.05); Znpp administration blunted the
effects of BMSCs only on CXCL1 mRNA expression (p < 0.05). Hemin treatment after BMSC was also associated with decreased CXCL1 and CXCL2
mRNA vs. ALF (p < 0.05). Treatment groups: control, ALF, ALF followed by intravenous MSCs (ALF +MSC) 1 h post-induction, ALF followed by
MSCs and Znpp (ALF +MSC + Znpp) 1 h post-induction, and ALF followed by hemin (ALF + hemin) 1 h post-induction. Data are mean ± SD.
(*p < 0.05 vs. control group; $p < 0.05 vs. ALF group; # p < 0.05 vs. ALF +MSC group). Abbreviations: ALF acute liver failure, BMSCs bone marrow-derived
mesenchymal stem cells, D-Gal d-Galactosamine, FITC fluorescein isothiocyanate, HO-1 heme oxygenase-1, LPS lipopolysaccharide, Znpp
zinc protoporphyrin
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Fig. 4 BMSCs reduce hepatocyte apoptosis and promote proliferation via induction of HO-1 in the setting of ALF. a TUNEL (marking apoptosis)
and Ki67 (a proliferation marker) in livers 72 h after D-Gal/LPS (magnification × 200). b Numbers of TUNEL- + and Ki67- + cells in each group
(n = 6 per group). ALF livers had the highest number of TUNEL- + cells. BMSCs significantly reduced numbers of TUNEL- + cells (p < 0.05); Znpp
blunted the anti-apoptotic effect of BMSCs (p < 0.05). BMSC and hemin also resulted in significantly less TUNEL- + cells vs. ALF (p < 0.05). BMSCs
significantly increased the number of ki67- + cells relative to ALF livers (p < 0.05); Znpp blunted the BMSC effect on proliferation (p < 0.05). BMSC
plus hemin also increased the number of ki67-positive cells vs. ALF livers (p < 0.05). c Western blot of Bcl-2 and Bax protein levels (normalized to
β-actin standard). d The Bcl-2/Bax ratio decreased significantly in ALF livers. BMSCs infusion increased the Bcl-2/Bax ratio (p < 0.05); Znpp blunted
this effect of BMSCs (p < 0.05). BMSCs plus hemin treatment also increased Bcl-2/Bax ratios vs. ALF livers (p < 0.05). Treatment groups: control, ALF,
ALF followed by intravenous MSCs (ALF + MSC) 1 h post-induction, ALF followed by MSCs and Znpp (ALF +MSC + Znpp) 1 h post-induction, and
ALF followed by hemin (ALF + hemin) 1 h post-induction. Data are mean ± SD. (*p < 0.05 vs. control group; $p < 0.05 vs. ALF group; #p < 0.05 vs.
ALF + MSC group). Abbreviations: ALF acute liver failure, BMSCs bone marrow-derived mesenchymal stem cells, D-Gal d-Galactosamine HO-1 heme
oxygenase-1, LPS lipopolysaccharide, TUNEL 2’-deoxyuridine 5’-triphosphatenick-end labeling, Znpp zinc protoporphyrin
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inhibition of the HO-1 restored the CXCL1 levels,
suggesting that CXCL1 mediated the protective effect of
HO-1 after MSCs transplantation.
ALF is associated with significant inflammation. We
evaluated the effects of BMSCs on cytokines such as IL-
1β, IL-6, and TNF-α, which are biomarkers closely asso-
ciated with severe inflammation [6]. Our study showed
that BMSCs significantly inhibited the expression of IL-
1β, IL-6, and TNF-α induced by D-Gal/LPS, and HO-1
played a key anti-inflammatory role. Downregulation of
HO-1 is associated with exacerbation of inflammatory
response by TNF-α in human monocytes [25]. In chronic
ethanol-induced liver injury, Bakhautdin et al. [41] re-
ported attenuation of TNF-α-induced cell death and oxi-
dative stress via HO-1. Several pathological factors trigger
NF-κB signaling, which regulates the expression of inflam-
matory cytokines. Our study showed that BMSCs mark-
edly inhibited the activation of NF-κB via induction of
HO-1. MAPKs play an important role in the regulation of
D-Gal-induced inflammation by controlling NF-κB activa-
tion [42]. We demonstrated that BMSCs inhibited JNK in
response to D-Gal/LPS, suggesting that MAPKs mediate
Fig. 5 BMSCs decrease inflammatory cytokines via HO-1 in the setting of ALF. a Western blot of phosphorylated P38 mitogen-activated protein
kinase (MAPK), extracellular-regulated protein kinases (Erk), C-Jun N-terminal kinase (JNK), nuclear factor kappa B (NF-κB) p65 (and β-actin standard).
Levels of JNK, p-p38, NF-κB p65 increased in ALF livers vs. controls. BMSCs decreased ALF levels of JNK, NF-κB p65; Znpp only blunted the BMSC
inhibition of NF-κB p65 expression. Hemin treatment also resulted only in reduction of NF-kB p65 protein. b NF-κB DNA binding activity (n = 6 per
group) increased significantly in ALF livers. BMSCs significantly reduced NF-κB DNA binding activity (p < 0.05). Znpp administration could reverse this
BMSC effect (p < 0.05). Hemin and BMSC were also associated with decreased NF-κB DNA binding activity vs. ALF livers (p < 0.05). c Enzyme-linked
immunosorbent assay of serum levels of IL-1β, IL-6, and TNF-α after D-Gal/LPS (n = 6 per group). Quantitative reverse transcription PCR for IL-1β, IL-6,
and TNF-α mRNA levels in livers. BMSCs infusion significantly decreased protein or mRNA levels of IL-1β, IL-6, and TNF-α (p < 0.05); Znpp administration
reversed this effect of the BMSCs (p < 0.05). Hemin and BMSCs were also associated with decreased protein and mRNA levels of IL-1β, IL-6, and TNF-α
(p < 0.05) vs. ALF livers. Treatment groups: control, ALF, ALF followed by intravenous MSCs (ALF +MSC) 1 h post-induction, ALF followed by MSCs and
Znpp (ALF +MSC + Znpp) 1 h post-induction, and ALF followed by hemin (ALF + hemin) 1 h post-induction. Data are mean ± SD. (*p < 0.05 vs. control
group; $p < 0.05 vs. ALF group; #p < 0.05 vs. ALF +MSC group). Abbreviations: ALF acute liver failure, BMSCs bone marrow-derived mesenchymal stem
cells, D-Gal d-Galactosamine, HO-1 heme oxygenase-1, IL interleukin, LPS lipopolysaccharide, TNF tumor necrosis factor, Znpp zinc protoporphyrin
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the suppression of BMSC-induced NF-κB activation by D-
Gal/LPS, which also explains the inhibition of neutrophils
during the anti-inflammatory response.
Our study limitations are as follows. First, the poten-
tial participation of factors/pathways between MSCs and
HO-1 has not been clarified, although our research sug-
gest an important role for Nrf2. The identifying task
would be time-consuming because it requires knockout
or other similar experiments. Next, our study was pre-
liminary because it was not carried out for a longer
period of time, as the ideal of MSCs alone as a liver dia-
lysis would not be expected to extend survival. In spite
of these limitations, our work provides a novel message
between BMSCs and HO-1 in ALF rats.
Conclusions
We demonstrated that BMSCs ameliorated ALF by in-
creasing the expression of HO-1, and reducing PMN
infiltration and function. BMSCs play an important anti-
inflammatory and anti-apoptotic role.
Additional files
Additional file 1: Figure S1. Characterization of BMSCs. (A) Morphology
of BMSCs at day 12 of culture. Isolated BMSCs grow as fibroblast-like cells.
Magnification × 50 and × 100. Scale bars = 100 μm. (B) MSC marker profile of
BMSCs. immunophenotype of BMSCs is determined by flow cytometry with
the use of labeled antibodies specific for the known markers (CD29, CD34,
CD44, CD45, and CD90), BMSCs isolated from rat were positive for CD29
(98.9%), CD44 (97.1%), and CD90 (99.2%) and negative for CD34 (0.8%) and
CD45 (2.0%), which meant high purity after the third passage. Abbreviations:
BMSCs bone marrow mesenchymal stem cells, CD cluster of differentiation,
PE P-phycoerythrin, FITC fluorescein isothiocyanate. (JPG 7121 kb)
Additional file 2: Figure S4. Gating strategy for neutrophils. Example
of gating of a blood sample for flow cytometry using physical
characteristics of granularity (FSC) and size (SSC). Neutrophils constituted
the largest population. (JPG 149 kb)
Additional file 3: Figure S5. Gating strategy for neutrophils.
Neutrophils were further gated to determine purity (CD11b FITC and
His 48 PE). (JPG 92 kb)
Additional file 4: Figure S2. In vivo fluorescence imaging of rats
3 days after injection with Dir-labeled mesenchymal stem cells. Strong
fluorescence was detected in the liver showing that BMSCs home to the
injured liver. Treatment groups: control, ALF, ALF followed by intravenous
MSCs (ALF + MSC) 1 h post-induction, ALF followed by MSCs and Znpp
(ALF +MSC + Znpp) 1 h post-induction, and ALF followed by hemin
(ALF + hemin) 1 h post-induction. Data are mean ± SD. (*p < 0.05 vs.
control group; $p < 0.05 vs. ALF group; #p < 0.05 vs. ALF + MSC group).
(JPG 2007 kb)
Additional file 5: Figure S3. Fluorescence microscopy of Dir-labeled
BMSCs engrafted in liver tissues, detected by fluorescence microscope. (A)
Dir-labeled BMSCs were detected in liver lobular parenchyma 3 days
post-transplantation. (B) Quantification of BMSCs in the livers of ALF +MSC
and ALF +MSC + Znpp groups. The distribution of Dir-labeled BMSCs in liver
tissues was observed by fluorescence microscope. Fluorescence microscope
exhibited that in ALF +MSC group and ALF +MSC + Znpp group, MSC
distributed in liver dispersedly. (JPG 4233 kb)
Abbreviations
ALF: Acute liver failure; ALT: Alanine aminotransferase; AST: Aspartate
transaminase; BMSCs: Bone marrow-derived mesenchymal stem cells;
CD: Cluster of differentiation; D-Gal: d-Galactosamine; Erk: Extracellular-
regulated protein kinase; FITC: Fluorescein isothiocyanate; HO: Heme
oxygenase; IL: Interleukin; JNK: C-Jun N-terminal kinase; LPS: Lipopolysaccharide;
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MPO: Myeloperoxidase; MSCs: Mesenchymal stem cells; NF: nuclear factor;
Nrf2: Nuclear factor-erythroid 2 p45-related factor 2; OLT: Orthotopic liver
transplantation; PE: P-phycoerythrin; PMN: Polymorphonuclear neutrophil;
TBIL: Total bilirubin; TNF: Tumor necrosis factor; TUNEL: 2’-deoxyuridine 5’-
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